Haemostatic therapies for acute spontaneous intracerebral haemorrhage

Study characteristicsWe found 12 randomised controlled trials, including 1732 participants, up to November 2017. Key resultsWe found moderate-quality evidence of harm from platelet transfusion for people who had used antiplatelet drugs until they had a brain haemorrhage.We found no evidence of either benefit or harm from other haemostatic therapies for people with brain haemorrhage. Quality of the evidenceOverall, the quality of the evidence was moderate to low.More information will become available from the 10 trials that are ongoing.2 Haemostatic therapies for acute spontaneous intracerebral haemorrhage (Review)